Dupont Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Dupont Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-18,251	Closed	-$1.18M	–	952
2017 Q4	$1.18M	Buy	18,251 +9,684	+113%	+$602K	0.03%	485
2017 Q3	$450K	Buy	+8,567	New	+$409K	0.01%	697
2016 Q3	–	Sell	-7,955	Closed	-$444K	–	655
2016 Q2	$444K	Sell	7,955 -5,938	-43%	-$289K	0.01%	595
2016 Q1	$468K	Hold	13,893	–	–	0.01%	552
2015 Q4	$627K	Sell	13,893 -362	-3%	-$15.6K	0.02%	550
2015 Q3	$563K	Buy	14,255 +4,925	+53%	+$280K	0.01%	522
2015 Q2	$579K	Hold	9,330	–	–	0.01%	499
2015 Q1	$584K	Hold	9,330	–	–	0.01%	495
2014 Q4	$526K	Buy	+9,330	New	+$411K	0.01%	542

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Dupont Capital Management's ANIP Position: Q1 2018 in Review

Dupont Capital Management sold out of ANI Pharmaceuticals (ANIP) in Q1 2018, closing a stake of 18,251 shares — an estimated $1.18M sold.

Dupont Capital Management first reported a position in ANIP in Q4 2014 and held it in 9 quarters. The position peaked at $1.18M in Q4 2017. 175 funds tracked by Wall St. Rank hold ANIP as of Q1 2018.

Dupont Capital Management reported no remaining ANI Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
Dupont Capital Management sold 18,251 ANI Pharmaceuticals shares in Q1 2018, an estimated $1.18M.
Dupont Capital Management first reported a position in ANI Pharmaceuticals in Q4 2014 and held it in 9 quarters.
Dupont Capital Management's ANI Pharmaceuticals position peaked at $1.18M in Q4 2017.
175 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2018.

Based on Dupont Capital Management's 13F filing for Q1 2018, filed 2 May 2018.